News

The Shanghai Canbi news column provides information on reference preparations, pharmaceutical intermediates, development of pharmaceutical raw materials and blood products in the field of biomedicine. Access to the latest and most comprehensive medical news policies through various global medical news platforms, collect the latest medical research and development data, take you to understand the latest trends and policies of the pharmaceutical industry, stay at home to read the latest global medical news and information.

• 
  PNAS parse! Developing novel cancer immunotherapies that target common genetic mutations!
  Recently, an international journal published in PNAS, entitled "Targeting loss of heterozygosity for cancer - specific immunotherapy" research report, the Johns Hopkins university school of medicine of institutions such as scientists have developed a new
  Tags：
  The number of readers：927
  Source：
  2021-03-25
• 
  Merck's oral selective P2X3 receptor antagonist, gefapixant, is under review in the United States
  Merck & Co (NYSE: MRK) today announced that the U.S. Food and Drug Administration (FDA) has accepted a new drug application (NDA) for gefapixant (MK-7264), an oral, selective P2X3 receptor antagonist for the treatment of adults with refractory chronic cou
  Tags：
  The number of readers：928
  Source：
  2021-03-10
• 
  First new drug in 20 years! AstraZeneca immunotoxin Lumoxiti has been approved in the European Union for the treatment of hair cell leukaemia (HCL)!
  The latest data according to the eu's new drug approval database, AstraZeneca (AstraZeneca) cancer drugs Lumoxiti (moxetumomab pasudotox) recently approved by the European commission (EC), the drug is a kind of CD - 22 restructuring to poison resistance,
  Tags：
  The number of readers：1175
  Source：EU Database for New Drug Approvals
  2021-02-13

Product Info

Product Name

Synonyms

CAS

Molecular Formula Upload

Contact Us

Company

Name

Tel

Email

Details

Submit

• Please fill in product name !
• CAS
• Please fill in your company information correctly!
• Please fill in liaison information correctly!
• Please fill in your telephone number correctly!
• Please fill in your email correctly!
• Please describe the problem of products!